Jan Theys

4.2k total citations
98 papers, 3.1k citations indexed

About

Jan Theys is a scholar working on Biotechnology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jan Theys has authored 98 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Biotechnology, 34 papers in Molecular Biology and 30 papers in Cancer Research. Recurrent topics in Jan Theys's work include Cancer Research and Treatments (40 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Virus-based gene therapy research (22 papers). Jan Theys is often cited by papers focused on Cancer Research and Treatments (40 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Virus-based gene therapy research (22 papers). Jan Theys collaborates with scholars based in Netherlands, Belgium and Germany. Jan Theys's co-authors include Philippe Lambin, Willy Landuyt, Ludwig J. Dubois, Marc Vooijs, Sandra Nuyts, Bradly G. Wouters, Jozef Anné, Lieve Van Mellaert, Roland K. Chiu and Arjan J. Groot and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Jan Theys

96 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Theys Netherlands	36	1.3k	1.0k	766	762	679	98	3.1k
Long H. Dang United States	27	1.5k 1.2×	890 0.9×	663 0.9×	623 0.8×	668 1.0×	85	3.2k
Ian Cheong United States	20	1.8k 1.4×	683 0.7×	660 0.9×	543 0.7×	718 1.1×	42	3.2k
Nam W. Kim United States	13	4.7k 3.6×	1.0k 1.0×	428 0.6×	231 0.3×	939 1.4×	17	7.9k
Stephen P. Naber United States	37	2.4k 1.8×	167 0.2×	836 1.1×	215 0.3×	1.9k 2.8×	87	4.6k
Uwe Zangemeister‐Wittke Switzerland	44	4.0k 3.0×	382 0.4×	662 0.9×	195 0.3×	1.6k 2.4×	108	5.6k
Jean‐Philippe Theurillat Switzerland	19	1.5k 1.2×	219 0.2×	396 0.5×	150 0.2×	588 0.9×	30	2.8k
William E. Fogler United States	38	2.0k 1.5×	282 0.3×	648 0.8×	157 0.2×	1.1k 1.5×	105	3.9k
Tapan K. Bera United States	34	1.5k 1.1×	466 0.5×	258 0.3×	85 0.1×	1.0k 1.5×	87	3.6k
Richard B. Halberg United States	28	1.3k 1.0×	110 0.1×	610 0.8×	103 0.1×	1.2k 1.8×	79	2.9k
Tracy M. Bryan Australia	36	5.8k 4.5×	544 0.5×	821 1.1×	87 0.1×	1.7k 2.5×	65	8.6k

Countries citing papers authored by Jan Theys

Since Specialization

Citations

This map shows the geographic impact of Jan Theys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Theys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Theys more than expected).

Fields of papers citing papers by Jan Theys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Theys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Theys. The network helps show where Jan Theys may publish in the future.

Co-authorship network of co-authors of Jan Theys

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Theys. A scholar is included among the top collaborators of Jan Theys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Theys. Jan Theys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dubois, Ludwig J., Ala Yaromina, Miriam van Dijk, et al.. (2025). Dietary enrichment with n-3 lc-PUFA-rich fish oil improves preclinical outcome of radiotherapy and anti-PD-L1 combination treatment. Cancer Treatment and Research Communications. 44. 100943–100943. 1 indexed citations

Worp, Wouter R. P. H. van de, Jan Theys, Frank Verhaegen, et al.. (2024). Targeted nutritional intervention attenuates experimental lung cancer cachexia. Journal of Cachexia Sarcopenia and Muscle. 15(5). 1664–1676. 3 indexed citations

Cong, Ying, et al.. (2024). Harnessing native-cryptic plasmids for stable overexpression of heterologous genes in Clostridium butyricum DSM 10702 for industrial and medical applications. Microbiological Research. 288. 127889–127889. 1 indexed citations

Yadati, Tulasi, Gert B. Eijkel, Benjamin Balluff, et al.. (2024). Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction‐associated steatohepatitis. FEBS Journal. 292(7). 1781–1797. 1 indexed citations

Worp, Wouter R. P. H. van de, Jan Theys, Brent van der Heyden, et al.. (2023). A novel orthotopic mouse model replicates human lung cancer cachexia. Journal of Cachexia Sarcopenia and Muscle. 14(3). 1410–1423. 9 indexed citations

Dubois, Ludwig J., et al.. (2023). Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia. Microbiology Spectrum. 11(6). e0245923–e0245923. 9 indexed citations

Lambin, Philippe, et al.. (2022). Heterologous Gene Regulation in Clostridia: Rationally Designed Gene Regulation for Industrial and Medical Applications. ACS Synthetic Biology. 11(11). 3817–3828. 6 indexed citations

Lieverse, R., Damiënne Marcus, Alexander M.A. van der Wiel, et al.. (2020). Human fibronectin extra domain B as a biomarker for targeted therapy in cancer. Molecular Oncology. 14(7). 1555–1568. 35 indexed citations

Mowday, Alexandra M., Janine N. Copp, Sophie P. Syddall, et al.. (2020). E. coli nitroreductase NfsA is a reporter gene for non-invasive PET imaging in cancer gene therapy applications. Theranostics. 10(23). 10548–10562. 21 indexed citations

10.

Spiegelberg, Linda, Stefan J. van Hoof, Rianne Biemans, et al.. (2019). Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity. Radiotherapy and Oncology. 141. 247–255. 22 indexed citations

11.

Ertaylan, Gökhan, Charlotte Le Cornet, Eline H. van Roekel, et al.. (2017). A Comparative Study on the WCRF International/University of Bristol Methodology for Systematic Reviews of Mechanisms Underpinning Exposure–Cancer Associations. Cancer Epidemiology Biomarkers & Prevention. 26(11). 1583–1594. 8 indexed citations

12.

Narayan, Ravi S., Tonny Lagerweij, Jaap van den Berg, et al.. (2017). Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma. Molecular Cancer Therapeutics. 17(2). 347–354. 19 indexed citations

13.

Yahyanejad, Sanaz, Stefan J. van Hoof, Jan Theys, et al.. (2015). An image guided small animal radiation therapy platform (SmART) to monitor glioblastoma progression and therapy response. Radiotherapy and Oncology. 116(3). 467–472. 18 indexed citations

14.

Timmermans, Leen, Roger Godschalk, Jan Theys, et al.. (2010). Diminished Carcinogen Detoxification Is a Novel Mechanism for Hypoxia-inducible Factor 1-mediated Genetic Instability. Journal of Biological Chemistry. 285(19). 14558–14564. 33 indexed citations

15.

Dubois, Ludwig J., Tom Dresselaers, Willy Landuyt, et al.. (2007). Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression. British Journal of Cancer. 96(5). 758–761. 10 indexed citations

16.

Chiu, Roland K., J Brun, Jan Theys, et al.. (2006). Lysine 63-Polyubiquitination Guards against Translesion Synthesis–Induced Mutations. PLoS Genetics. 2(7). e116–e116. 107 indexed citations

17.

Mengesha, Asferd, Ludwig J. Dubois, Philippe Lambin, et al.. (2006). Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated salmonella. Cancer Biology & Therapy. 5(9). 1120–1128. 70 indexed citations

18.

Wouters, Bradly G., Sherry A. Weppler, Marianne Koritzinsky, et al.. (2002). Hypoxia as a target for combined modality treatments. European Journal of Cancer. 38(2). 240–257. 140 indexed citations

19.

Nuyts, Sandra, Lieve Van Mellaert, Jan Theys, et al.. (2001). The Use of Radiation-Induced Bacterial Promoters in Anaerobic Conditions: A Means to Control Gene Expression inClostridium-Mediated Therapy for Cancer. Radiation Research. 155(5). 716–723. 55 indexed citations

20.

Landuyt, Willy, Jan Theys, Sandra Nuyts, et al.. (2001). Effect of TNP-470 (AGM-1470) on the Growth of Rat Rhabdomyosarcoma Tumors of Different Sizes. Cancer Investigation. 19(1). 35–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact